However, our results suggest that HOTAIRM1, GAS5, MZF1-AS1, and OIP5-AS1 could be potential biomarkers to help clinicians accurately stratify different asthma phenotypes, which would have an indirect impact on the early diagnosis and quality of life of asthmatic patients. This evidence concerns the gene GAS5 and asthma.